Viewing StudyNCT04216121



Ignite Creation Date: 2024-05-06 @ 2:05 PM
Last Modification Date: 2024-10-26 @ 1:25 PM
Study NCT ID: NCT04216121
Status: RECRUITING
Last Update Posted: 2024-07-01
First Post: 2019-12-09

Brief Title: LAT for Oligoprogressive NSCLC Treated With First-line OSImertinib
Sponsor: Universitaire Ziekenhuizen KU Leuven
Organization: Universitaire Ziekenhuizen KU Leuven

Conditions & Keywords Data

Conditions:
Name
Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
Keywords:
Name View
Local ablative therapy View
First line osimertinib View